Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Rouen hospital checks accuracy of COVID-19 antibody tests

NCT ID NCT04707833

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early This study
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study aimed to check how accurate several COVID-19 antibody tests are. Researchers used blood samples from 101 adults, including some taken before the pandemic and some from people with other infections. The goal was to see which tests best detect past COVID-19 infection.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

101 people

The number who actually took part.

Started

Nov 2020

Finished

Dec 2021

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 80 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: The inclusion criteria in the retrospective "Negative/Potentially Interfering" group are as follows : * Adult patient sampled prior to the onset of the COVID-19 epidemic (before January 2020) * Patient presenting a coronavirus infection other than SARS-CoV-2, or other respiratory viral infections (influenza, metapneumovirus) * Patients for whom a serum is kept in the biocollection declared under the number AC-2014-2293 and kept in the Institute of Clinical Biology, University Hospital of Rouen. The criteria for inclusion in the "acute point infection" group are as follows: * Patients screened by a positive RT-PCR for an SARS-CoV-2 infection * Patients aged ≥ 18 years old * Patients taken in charge in the emergency room / in a unit / in COVID resuscitation at the Rouen University Hospital. * Patients having read and understood the briefing note * Non-opposition to participation in the study The criteria for inclusion in the "Sequential acute infection" group are as follows: * Patients with positive RT-PCR for CoV-2-SARS infection * Patients aged ≥ 18 years old * Taken care of in a COVID unit at the Rouen University Hospital * Having read and understood the briefing note and signed the informed consent form The criteria for inclusion in the "Convalescent" group are as follows: * Caregivers working at the UH of Rouen * Screened by positive RT-PCR for SARS-CoV-2 infection, * Healed for at least one month at the time of inclusion * Having read and understood the briefing note and signed the informed consent form Exclusion Criteria: * Minor person * Known Pregnancy * Person deprived of liberty by an administrative or judicial decision or person placed under judicial protection / subtutorship or guardianship * Person not affiliated with social security * Person who does not understand and speak French

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Corona virus infection are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Rouen University Hospital

    Rouen, 760031, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.